Tokyo, Japan

Fumimaro Takaku


 

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 165(Granted Patents)


Location History:

  • Utsunomiya, JP (1981 - 1982)
  • Tokyo, JP (1992 - 2006)

Company Filing History:


Years Active: 1981-2006

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Fumimaro Takaku: Innovator in Gamma Retinoic Acid Receptor Research

Introduction

Fumimaro Takaku, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of biomedicine. With an impressive portfolio of 10 patents, his work primarily focuses on gamma retinoic acid receptors and their applications.

Latest Patents

Takaku's latest patents include innovative discoveries related to nucleic acid encoding gamma retinoic acid receptor fusion proteins. This novel gamma retinoic acid receptor is encoded by cDNA carried on the plasmid pGEM-hRARγ, which has been deposited with the American Type Culture Collection for patent purposes. Additionally, the patents disclose chimeric receptor proteins containing at least one functional domain from the new gamma retinoic acid receptor.

Career Highlights

Throughout his career, Fumimaro Takaku has collaborated with leading companies in the industry, including Morinaga Milk Industry Co., Ltd. and The Green Cross Corporation. His extensive experience and innovative research have positioned him as a pivotal figure in the development of receptor proteins that have potential therapeutic applications.

Collaborations

Takaku has also worked alongside notable colleagues such as Takashi Ishikawa and Michio Imawari. Their collaborative efforts in research and development have contributed to the advancement of knowledge in the field of gamma retinoic acid receptors.

Conclusion

Fumimaro Takaku stands out as a prominent inventor in Tokyo's biomedicine scene. His groundbreaking patent work and collaborations continue to have a lasting impact on the study of gamma retinoic acid receptors, opening doors to potential innovations in medication and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…